NIAID director Anthony Fauci, MD, and coauthors emphasize the need for a global response to COVID-19.

The new consensus guidelines apply to women who have had breast cancer in the past and were at least 75 years old.

New research shows that gene activity could be used to predict tumors most likely to benefit from “genotoxic” therapies

A meta-analysis of 18 studies found that late diagnosis and mortality were significantly higher among American women than African women.

First-line Lenvima plus Keytruda yields better overall survival for patients with metastatic kidney cancer.

Bamlanivimab and etesevimab may be given to people with mild to moderate COVID-19 who are at high risk for progression to severe disease.

Despite limited testing and clinical visits, 95% of the study population was able to achieve a sustained virological response.

After approval of the latest cellular therapy for non-Hodgkin lymphoma, the big challenge is how to extend it to common solid tumors.

But this benefit applied only to those individuals who initiated aspirin use at an earlier age.

Study shows that screening kits from a drive-by flu vaccination clinic increased access to colorectal cancer screening for Black Americans